NFE2L2 and lung cancer: Unlike many other tumor entities such as lung cancers (Shibata et al., 2008; Kim et al., 2010), however, PDACs rarely harbor somatic mutations in either the KEAP1 or NRF2 genes that usually result in an active NRF2.